SCHEMBL22345974

SCHEMBL22345974

N[CH]C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3188709 0.70
SCHEMBL899065 0.70
Acrylamide SCHEMBL1921274 0.70
SCHEMBL2366958 0.70
SCHEMBL11312483 0.70
SCHEMBL245241 0.70
SCHEMBL292266 0.70
SCHEMBL156118 0.70
SCHEMBL25840 0.70
SCHEMBL156117 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1230196-A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. THOMAE GMBH DR K (DE) 1999-09-29 CN claimed
CN-1084173-A 1-azabicyclo [3,2,0] hept-2-ene\"-2-carboxylic acid derivative and preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1994-03-23 CN claimed
EP-4310076-A1 COMPOUND COMPRISING PYRROLIDINE AS LINKER, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Bead Tech Inc. (KR) 2024-01-24 EP disclosed
US-20220242913-A1 NOVEL INTERMEDIATE USED FOR BIOLOGICALLY ACTIVE POLYPEPTIDE AND METHOD FOR PREPARING SAME HANMI FINE CHEMICAL CO., LTD. (KR) 2022-08-04 US disclosed
EP-3939990-A1 NOVEL INTERMEDIATE USED FOR BIOLOGICALLY ACTIVE POLYPEPTIDE AND METHOD FOR PREPARING SAME Hanmi Fine Chemical Co., Ltd. (KR) 2022-01-19 EP disclosed
WO-2020167010-A1 NOVEL INTERMEDIATE USED FOR BIOLOGICALLY ACTIVE POLYPEPTIDE AND METHOD FOR PREPARING SAME 한미정밀화학주식회사 2020-08-20 WO disclosed
CN-105452398-B Composition for ink, ink jet recording method and tingle body using this composition for ink 日本化药株式会社 2018-07-10 CN disclosed
CN-101611053-B Anti-angiogenic compounds COVX TECHNOLOGIES IRELAND LTD 2015-06-03 CN disclosed
CN-103889968-A Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy ABBOTT GMBH & AMP 2014-06-25 CN disclosed
CN-102083797-B Tetrahydroisoquinolines, pharmaceutical compositions containing them and their use in therapy ABBOTT GMBH & CO KG 2014-06-04 CN disclosed
CN-101265368-B Pigment dispersion composition, optical solidifying composition, color filter and manufacturing method thereof FUJI PHOTO FILM CO LTD 2013-07-31 CN disclosed
CN-1333766-A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors AVENTIS PHARM PROD INC (US) 2002-01-30 CN disclosed
CN-1289324-A Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound AVENTIS PHARMA INC (US) 2001-03-28 CN disclosed
CN-1054598-C Pharmacologically active hydrazine derivatives and processes for preparation thereof NORVATIS CO (CH) 2000-07-19 CN disclosed
CN-1230196-A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. THOMAE GMBH DR K (DE) 1999-09-29 CN disclosed
CN-1215401-A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists ABBOTT LAB (US) 1999-04-28 CN disclosed
CN-1161834-A Prepration method for medicinal composition containing triazolyl derivative MERCK SHARP & DOHME (GB) 1997-10-15 CN disclosed
CN-1084173-A 1-azabicyclo [3,2,0] hept-2-ene\"-2-carboxylic acid derivative and preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1994-03-23 CN disclosed
CN-1068333-A Has hydrazine analog derivative of pharmacologically active and preparation method thereof CIBA GEIGY AG (CH) 1993-01-27 CN disclosed
CN-87107753-A New substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agent 1988-06-29 CN disclosed